MedPath
TGA Approval

POLIVY polatuzumab vedotin 140 mg powder for injection vial (314866)

314866

POLIVY polatuzumab vedotin 140 mg powder for injection vial

Roche Products Pty Ltd

October 21, 2019

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/114a6798fe27148be8309747c39ec966.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/d93ed5fa590286007fca7e1c2755f92b.pdf

Active Ingredients

polatuzumab vedotin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

POLIVY polatuzumab vedotin 140 mg powder for injection vial (314866) - TGA 批准文号 | MedPath